Literature DB >> 15811443

Firms fill antiretroviral gap in South Africa.

Lester Venter1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15811443     DOI： 10.1016/S0140-6736(05)74793-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Implementing 'universal' access to antiretroviral treatment in South Africa: a scoping review on research priorities.

Authors:  Hanlie Myburgh; Lindsey Reynolds; Graeme Hoddinott; Dianne van Aswegen; Nelis Grobbelaar; Colette Gunst; Karen Jennings; James Kruger; Francoise Louis; Constance Mubekapi-Musadaidzwa; Lario Viljoen; Dillon Wademan; Peter Bock
Journal:  Health Policy Plan       Date:  2021-06-25       Impact factor: 3.344

2.  Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.

Authors:  Gitau Mburu; Aung Zayar Paing; Nwe Ni Myint; Win Di; Kaung Htet Thu; Mala Ram; Christopher J Hoffmann; Bangyuan Wang; Soe Naing
Journal:  J Int AIDS Soc       Date:  2016-10-25       Impact factor: 5.396

3.  Outcomes of HIV treatment from the private sector in low-income and middle-income countries: a systematic review protocol.

Authors:  Gitau Mburu; Ewemade Igbinedion; Sin How Lim; Aung Zayar Paing; Siyan Yi; Stefan Elbe; Grace W Mwai
Journal:  BMJ Open       Date:  2020-01-08       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.